Literature DB >> 19402077

Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.

Katsunori Imai1, Toru Beppu, Yoshiharu Nakayama, Takatoshi Ishiko, Kei Horino, Hiroyuki Komori, Toshiro Masuda, Hiromitsu Hayashi, Hirohisa Okabe, Yoshihumi Baba, Masayuki Watanabe, Hiroshi Takamori, Kazuo Awai, Yasuyuki Yamashita, Hideo Baba.   

Abstract

BACKGROUND: Poorly differentiated hepatocellular carcinoma (HCC) has a malignant potential such as frequent microvascular invasion even if the tumor is smaller than 3 cm in diameter. The aim of this study was to clarify the preoperative predictors of poorly differentiated HCC for safe local ablation therapy.
METHODS: Sixty-six patients underwent a hepatic resection for solitary small-sized HCC (<or=3 cm) were included in this study. According to the postoperative histological examination, the patients were divided into a "poorly differentiated group" (n = 17) and a "well/moderately differentiated group" (n = 49). This study investigated the clinicopathological factors and imaging findings, and elucidated the predictive factors of the poorly differentiated type.
RESULTS: In a univariate analysis, serum hepatitis B surface antigen positive, hepatitis C virus antibody negative, alpha-fetoprotein level, des-gamma-carboxy prothrombin level, and a high contrast-to-noise ratio (CNR) in T2-weighted MR imaging were significantly associated with the poorly differentiate type. In a multivariate analysis, a high CNR in T2-weighted MR imaging was the only independent predictor of the poorly differentiated type. In the postoperative pathological findings, portal vein invasion and intrahepatic metastasis were significantly frequent in the poorly differentiated group.
CONCLUSIONS: The CNR in T2-weighted MR imaging is a useful tool to predict poorly differentiated HCC preoperatively.

Entities:  

Mesh:

Year:  2009        PMID: 19402077     DOI: 10.1002/jso.21302

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.

Authors:  Hidetoshi Nitta; Shigeki Nakagawa; Takayoshi Kaida; Kota Arima; Takaaki Higashi; Katsunobu Taki; Hirohisa Okabe; Hiromitsu Hayashi; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Toru Beppu; Hideo Baba
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

2.  In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

Review 3.  The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.

Authors:  Toru Beppu; Shigeki Nakagawa; Hidetoshi Nitta; Hirohisa Okabe; Takayoshi Kaida; Katsunori Imai; Hiromitsu Hayashi; Yuki Koga; Kunitaka Kuramoto; Daisuke Hashimoto; Yo-Ichi Yamashita; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  J Clin Transl Hepatol       Date:  2017-05-10

4.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation.

Authors:  Yoshiyuki Ida; Hideyuki Tamai; Naoki Shingaki; Ryo Shimizu; Shuya Maeshima; Takao Maekita; Mikitaka Iguchi; Masaki Terada; Masayuki Kitano
Journal:  Cancer Imaging       Date:  2020-10-19       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.